Baidu
map

JCEM:胰岛素抵抗与处于骨峰值的非糖尿病人的骨密质大小有关

2017-06-19 MedSci MedSci原创

在这群非糖尿病人的骨峰值期,胰岛素抵抗与小梁骨和骨密质大小成反比。在调整了身体成分、肌肉大小或功能或性类固醇水平后,这些关联仍持续存在,这表明胰岛素抵抗对骨骼几何结构的影响是独立的。

背景:
在2型糖尿病中,尽管保持区域骨矿物质密度,但骨折的风险却增加了。虽然这一明显的悖论在一定程度上可以解释为胰岛素抵抗影响骨结构和/或物质特性,但关于研究胰岛素抵抗与骨几何结构之间的关系的研究很少。

目的:
在骨峰值时期的非糖尿病患者中探索这种联系。

设计:
在一所大学的研究中心,招募了996名年龄在25岁到45岁之间的非糖尿病男性患者。此研究采用基于人群的横断面同胞配对法。

主要结果测量:
运用抗胰岛素性稳态模式评估法(HOMA-IR)评估胰岛素抵抗,用空腹血清样本测量胰岛素和葡萄糖。在桡骨远端、桡、胫骨干上,使用外周定量计算机断层扫描术评估骨几何结构。

结果:
在年龄、身高和体重调整分析的情况下,HOMA-IR与位于桡骨远端的小梁区域、皮质区、骨膜和骨内周、桡骨和胫骨干的极性强度指数呈负相关(β≤ 0.13, P < 0.001)。在对经双能量x射线扫描吸光测定法得出的身体成分、骨代谢标记、肌肉大小或功能测量、脂联素、瘦素、胰岛素样生长因子1或性类固醇水平进行调整后,这些关联基本上保持不变。

结论:
在这群非糖尿病人的骨峰值期,胰岛素抵抗与小梁骨和骨密质大小成反比。在调整了身体成分、肌肉大小或功能或性类固醇水平后,这些关联仍持续存在,这表明胰岛素抵抗对骨骼几何结构的影响是独立的。

原始出处
Charlotte Verroken, Hans-Georg Zmierczak, Stefan Goemaere,et al. Insulin Resistance Is Associated With Smaller Cortical Bone Size in Nondiabetic Men at the Age of Peak Bone Mass. JCEM. 2017 June.

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2028411, encodeId=0b71202841106, content=<a href='/topic/show?id=dbec10164ed3' target=_blank style='color:#2F92EE;'>#骨峰值#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=101647, encryptionId=dbec10164ed3, topicName=骨峰值)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ec37461, createdName=szhvet, createdTime=Wed Nov 22 09:15:00 CST 2017, time=2017-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1749749, encodeId=89971e49749b8, content=<a href='/topic/show?id=be7c8385345' target=_blank style='color:#2F92EE;'>#胰岛#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=83853, encryptionId=be7c8385345, topicName=胰岛)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a7a536274692, createdName=baoya, createdTime=Sun Jul 16 06:15:00 CST 2017, time=2017-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2062989, encodeId=04c720629897e, content=<a href='/topic/show?id=14fb10264d7' target=_blank style='color:#2F92EE;'>#JCE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10264, encryptionId=14fb10264d7, topicName=JCE)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e656479, createdName=achengzhao, createdTime=Sun Jul 23 14:15:00 CST 2017, time=2017-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1777607, encodeId=b0e81e7760760, content=<a href='/topic/show?id=eb9610265ed' target=_blank style='color:#2F92EE;'>#JCEM#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10265, encryptionId=eb9610265ed, topicName=JCEM)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2a4439169927, createdName=smallant2015, createdTime=Mon Jan 22 11:15:00 CST 2018, time=2018-01-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1991167, encodeId=1746199116ea0, content=<a href='/topic/show?id=b29c99594dd' target=_blank style='color:#2F92EE;'>#非糖尿病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99594, encryptionId=b29c99594dd, topicName=非糖尿病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=467c360, createdName=yuanming7, createdTime=Wed Dec 13 18:15:00 CST 2017, time=2017-12-13, status=1, ipAttribution=)]
    2017-11-22 szhvet
  2. [GetPortalCommentsPageByObjectIdResponse(id=2028411, encodeId=0b71202841106, content=<a href='/topic/show?id=dbec10164ed3' target=_blank style='color:#2F92EE;'>#骨峰值#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=101647, encryptionId=dbec10164ed3, topicName=骨峰值)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ec37461, createdName=szhvet, createdTime=Wed Nov 22 09:15:00 CST 2017, time=2017-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1749749, encodeId=89971e49749b8, content=<a href='/topic/show?id=be7c8385345' target=_blank style='color:#2F92EE;'>#胰岛#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=83853, encryptionId=be7c8385345, topicName=胰岛)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a7a536274692, createdName=baoya, createdTime=Sun Jul 16 06:15:00 CST 2017, time=2017-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2062989, encodeId=04c720629897e, content=<a href='/topic/show?id=14fb10264d7' target=_blank style='color:#2F92EE;'>#JCE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10264, encryptionId=14fb10264d7, topicName=JCE)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e656479, createdName=achengzhao, createdTime=Sun Jul 23 14:15:00 CST 2017, time=2017-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1777607, encodeId=b0e81e7760760, content=<a href='/topic/show?id=eb9610265ed' target=_blank style='color:#2F92EE;'>#JCEM#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10265, encryptionId=eb9610265ed, topicName=JCEM)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2a4439169927, createdName=smallant2015, createdTime=Mon Jan 22 11:15:00 CST 2018, time=2018-01-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1991167, encodeId=1746199116ea0, content=<a href='/topic/show?id=b29c99594dd' target=_blank style='color:#2F92EE;'>#非糖尿病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99594, encryptionId=b29c99594dd, topicName=非糖尿病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=467c360, createdName=yuanming7, createdTime=Wed Dec 13 18:15:00 CST 2017, time=2017-12-13, status=1, ipAttribution=)]
    2017-07-16 baoya
  3. [GetPortalCommentsPageByObjectIdResponse(id=2028411, encodeId=0b71202841106, content=<a href='/topic/show?id=dbec10164ed3' target=_blank style='color:#2F92EE;'>#骨峰值#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=101647, encryptionId=dbec10164ed3, topicName=骨峰值)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ec37461, createdName=szhvet, createdTime=Wed Nov 22 09:15:00 CST 2017, time=2017-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1749749, encodeId=89971e49749b8, content=<a href='/topic/show?id=be7c8385345' target=_blank style='color:#2F92EE;'>#胰岛#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=83853, encryptionId=be7c8385345, topicName=胰岛)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a7a536274692, createdName=baoya, createdTime=Sun Jul 16 06:15:00 CST 2017, time=2017-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2062989, encodeId=04c720629897e, content=<a href='/topic/show?id=14fb10264d7' target=_blank style='color:#2F92EE;'>#JCE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10264, encryptionId=14fb10264d7, topicName=JCE)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e656479, createdName=achengzhao, createdTime=Sun Jul 23 14:15:00 CST 2017, time=2017-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1777607, encodeId=b0e81e7760760, content=<a href='/topic/show?id=eb9610265ed' target=_blank style='color:#2F92EE;'>#JCEM#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10265, encryptionId=eb9610265ed, topicName=JCEM)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2a4439169927, createdName=smallant2015, createdTime=Mon Jan 22 11:15:00 CST 2018, time=2018-01-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1991167, encodeId=1746199116ea0, content=<a href='/topic/show?id=b29c99594dd' target=_blank style='color:#2F92EE;'>#非糖尿病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99594, encryptionId=b29c99594dd, topicName=非糖尿病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=467c360, createdName=yuanming7, createdTime=Wed Dec 13 18:15:00 CST 2017, time=2017-12-13, status=1, ipAttribution=)]
    2017-07-23 achengzhao
  4. [GetPortalCommentsPageByObjectIdResponse(id=2028411, encodeId=0b71202841106, content=<a href='/topic/show?id=dbec10164ed3' target=_blank style='color:#2F92EE;'>#骨峰值#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=101647, encryptionId=dbec10164ed3, topicName=骨峰值)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ec37461, createdName=szhvet, createdTime=Wed Nov 22 09:15:00 CST 2017, time=2017-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1749749, encodeId=89971e49749b8, content=<a href='/topic/show?id=be7c8385345' target=_blank style='color:#2F92EE;'>#胰岛#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=83853, encryptionId=be7c8385345, topicName=胰岛)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a7a536274692, createdName=baoya, createdTime=Sun Jul 16 06:15:00 CST 2017, time=2017-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2062989, encodeId=04c720629897e, content=<a href='/topic/show?id=14fb10264d7' target=_blank style='color:#2F92EE;'>#JCE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10264, encryptionId=14fb10264d7, topicName=JCE)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e656479, createdName=achengzhao, createdTime=Sun Jul 23 14:15:00 CST 2017, time=2017-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1777607, encodeId=b0e81e7760760, content=<a href='/topic/show?id=eb9610265ed' target=_blank style='color:#2F92EE;'>#JCEM#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10265, encryptionId=eb9610265ed, topicName=JCEM)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2a4439169927, createdName=smallant2015, createdTime=Mon Jan 22 11:15:00 CST 2018, time=2018-01-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1991167, encodeId=1746199116ea0, content=<a href='/topic/show?id=b29c99594dd' target=_blank style='color:#2F92EE;'>#非糖尿病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99594, encryptionId=b29c99594dd, topicName=非糖尿病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=467c360, createdName=yuanming7, createdTime=Wed Dec 13 18:15:00 CST 2017, time=2017-12-13, status=1, ipAttribution=)]
    2018-01-22 smallant2015
  5. [GetPortalCommentsPageByObjectIdResponse(id=2028411, encodeId=0b71202841106, content=<a href='/topic/show?id=dbec10164ed3' target=_blank style='color:#2F92EE;'>#骨峰值#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=101647, encryptionId=dbec10164ed3, topicName=骨峰值)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ec37461, createdName=szhvet, createdTime=Wed Nov 22 09:15:00 CST 2017, time=2017-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1749749, encodeId=89971e49749b8, content=<a href='/topic/show?id=be7c8385345' target=_blank style='color:#2F92EE;'>#胰岛#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=83853, encryptionId=be7c8385345, topicName=胰岛)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a7a536274692, createdName=baoya, createdTime=Sun Jul 16 06:15:00 CST 2017, time=2017-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2062989, encodeId=04c720629897e, content=<a href='/topic/show?id=14fb10264d7' target=_blank style='color:#2F92EE;'>#JCE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10264, encryptionId=14fb10264d7, topicName=JCE)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e656479, createdName=achengzhao, createdTime=Sun Jul 23 14:15:00 CST 2017, time=2017-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1777607, encodeId=b0e81e7760760, content=<a href='/topic/show?id=eb9610265ed' target=_blank style='color:#2F92EE;'>#JCEM#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10265, encryptionId=eb9610265ed, topicName=JCEM)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2a4439169927, createdName=smallant2015, createdTime=Mon Jan 22 11:15:00 CST 2018, time=2018-01-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1991167, encodeId=1746199116ea0, content=<a href='/topic/show?id=b29c99594dd' target=_blank style='color:#2F92EE;'>#非糖尿病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99594, encryptionId=b29c99594dd, topicName=非糖尿病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=467c360, createdName=yuanming7, createdTime=Wed Dec 13 18:15:00 CST 2017, time=2017-12-13, status=1, ipAttribution=)]

相关资讯

Diabetes:3-羟基异丁酸和FGF21代谢改变与蛋白质诱导的胰岛素抵抗有关!

这些研究结果表明3-HIB和FGF21可能参与了人类蛋白质介导的胰岛素抵抗。

Diabetes:SIRT6能阻止肥胖相关的组织炎症和胰岛素抵抗进展

肥胖相关的胰岛素抵抗与巨噬细胞聚集和随后局部组织中细胞因子的释放密切相关。Sirtuin(SIRT)6是沉默信息调节蛋白家族成员之一,是一种依赖于烟酰胺腺嘌呤二核苷酸(NAD+)的组蛋白去乙酰化酶及ADP-核糖基转移酶的蛋白酶。

Free Radic Biol Med:老年人超重导致骨骼肌自噬损伤

近来,研究者研究并发表了老年人超重(未达到肥胖)对骨骼肌组织的影响,研究者发现超重导致了蛋白分解的加强:超重老年人中组织的合成代谢活动成渐进性加强,而这是为了对抗导致肌肉消耗的分解代谢活动的加强。

Neurology:中年肥胖患者胰岛素抵抗与脑血管反应性降低相关!

由此可见,IR与CVR下降相关;这种相关性似乎是由IR程度所驱动,而不是肥胖。这些很少报道的结果表明肥胖的具有显著IR而不是2型糖尿病患者的中年人中存在明显的脑血管功能障碍。这些功能性的血管异常可能有助于解释IR、糖尿病和老年痴呆症之间的相关性,并建议以改善IR或CVR干预可能有助于预防晚期生活的认知下降。

Diabetes Obes Metab:利拉鲁肽对膳食脂质诱导的胰岛素抵抗的影响!

由此可见,利拉鲁肽能够减弱富含SFA饮食诱导的胰岛素抵抗。这种效应可能与改善微血管功能和调节骨骼肌中的TxNIP和AMPK通路相关。

Thromb Haemost:增加人类凝血因子活性和表达的不是脂肪肝!

2017年1月,发表在《Thromb Haemost》的一项研究,得出了会增加人类凝血因子活性和表达的是肥胖或胰岛素抵抗而非肝脏脂肪的结论。肝脏脂肪的增加可因胰岛素抵抗和脂肪组织炎症造成,或由rs738409中的PNPLA3的常见I148M变异体造成,但是脂肪肝缺乏这些特征。研究人员假设,是肥胖/胰岛素抵抗而非肝脏脂肪增加循环凝血因子活性。我们测量了92名研究对象的凝血酶原时间(PT)、活化部分凝

Baidu
map
Baidu
map
Baidu
map